Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04050215Phase 2Completed
Phase 2, open-label, single-arm trial, sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Intended and implemented management changes. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04050215.